ZS turns healthcare data into actionable insights
ZS partners with life sciences companies to deliver transformative outcomes for patients through a path led by data, analytics, technology and end-to-end expertise. We know that the next cure can’t wait.
Analytics that reveal answers
There is already a galaxy of life sciences data that could lead to the next cure. We’ll partner with you to make sense of it and chart a bold new path underpinned by analytics that drive decision-making.
Patients at the center
We’ll help you deliver sustainable solutions to help more patients—new treatments for rare diseases and efficient ways to deliver therapies to larger populations.
Technology that narrows the gaps
Optimizing clinical development, operations and patient experience can shorten the gap between ideas and therapies. Predictive medicine and digital technology bring needed efficiencies to R&D activities.
People who make a difference
Our diverse team of R&D and technology experts represents the range of backgrounds, experience and mindsets necessary to innovate—leaving legacy models and solutions behind.
Insights
As they help life sciences make new discoveries through R&D, our experts lend their own insights and analysis.
Unlocking the insights beyond the surface
Watch our video on how we’re accelerating R&D with data and analytics.
Why ZSers are excited about R&D
Leaders in research and development at ZS share their thoughts on the issues that inspire their passion and why this is an exciting time for their industry.
- Video 1
- Video 2
It’s time for life sciences to revolutionize R&D
Innovation isn’t done in silos. That’s why our experts support life sciences’ R&D efforts, from real-world data to artificial intelligence to clinical trial design and all points in between.
“I hope that we get to a place where clinical trials are considered part of the care that a patient can partner with their doctor on—more a continuum of care.”
“Knowing my team has the ability to impact patients’ lives in a positive way is pretty incredible. At the heart of it, we’re all patients.”
“Creating this connected ecosystem that can impact a patient's overall health wasn’t possible 30 years ago. I find this innovative part quite exciting.”
“Due to AI, we're going to see exponential productivity in pharma R&D. My hunch is over the next decade we will see a reversal of Eroom’s Law.”
“We make sure there are no silos in our business. We spend time focusing on finding points of intersection where we can really add more value.”
“It’s exciting to see that we are starting to find and develop a very effective treatment in many areas to cure some really, really tough conditions.”
“Conducting innovative research that will help cure diseases while staying ethical and keeping patients at the center will help bring forward winners.”
“We can play a very strong role in not only catalyzing innovation, but also making sure it reaches those patients who need it the most.”
- section 1
- section 2
- section 3